Inhibition by cholinergic agonists of the prolactin release induced by morphine
- PMID: 503252
- DOI: 10.1007/BF00501389
Inhibition by cholinergic agonists of the prolactin release induced by morphine
Abstract
The cholinergic agonists, pilocarpine, physostigmine and nicotine, inhibited the prolactin release induced by morphine in male rats in vivo. Pilocarpine also inhibited the release of prolactin induced by beta-endorphin or metoclopramide without affecting the basal and haloperidol-stimulated serum prolactin levels. The inhibitory effect of pilocarpine on the morphine-stimulated release of prolactin was antagonized by concurrent administration of atropine but not by atropine methylnitrate or by mecamylamine, while the inhibition by nicotine was antagonized by mecanylamine but not by atropine. The stimulation of prolactin release by morphine and its reversal by pilocarpine were observed after the administration of haloperidol or alpha-methyltyrosine. These results suggest that the central cholinergic system exertes an inhibitory influence on the prolactin release induced by morphine or beta-endorphin and the cholinergic inhibition is not mediated via catecholaminergic neurons.
Similar articles
-
Evidence for adrenergic mediation of cholinergic inhibition of prolactin release.Endocrinology. 1976 Sep;99(3):775-9. doi: 10.1210/endo-99-3-775. Endocrinology. 1976. PMID: 954668
-
Interaction of morphine with the cholinergic system on prolactin release.Proc Soc Exp Biol Med. 1981 Apr;166(4):542-5. doi: 10.3181/00379727-166-41105. Proc Soc Exp Biol Med. 1981. PMID: 7220547 No abstract available.
-
Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.Neuroendocrinology. 1992 May;55(5):519-28. doi: 10.1159/000126176. Neuroendocrinology. 1992. PMID: 1350068
-
Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.J Comp Physiol Psychol. 1972 Jun;79(3):394-413. doi: 10.1037/h0032830. J Comp Physiol Psychol. 1972. PMID: 5054476 No abstract available.
-
Discriminative stimulus effects of cholinergic agonists and the actions of their antagonists.Psychopharmacol Ser. 1988;4:32-43. doi: 10.1007/978-3-642-73223-2_3. Psychopharmacol Ser. 1988. PMID: 3293044 Review.
Cited by
-
Venous plasma nicotine correlates of hormonal effects of tobacco smoking.Pharmacol Biochem Behav. 2010 Apr;95(2):209-15. doi: 10.1016/j.pbb.2010.01.007. Epub 2010 Jan 25. Pharmacol Biochem Behav. 2010. PMID: 20100507 Free PMC article.
-
Drug-induced changes in prolactin secretion. Clinical implications.Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):463-98. doi: 10.1007/BF03259897. Med Toxicol Adverse Drug Exp. 1988. PMID: 3063922 Review.
-
Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among nonsmoking women seeking in vitro fertilization.Environ Toxicol Pharmacol. 2012 Nov;34(3):761-7. doi: 10.1016/j.etap.2012.09.010. Epub 2012 Sep 23. Environ Toxicol Pharmacol. 2012. PMID: 23046534 Free PMC article.
-
Genome-wide Interaction Study Implicates VGLL2 and Alcohol Exposure and PRL and Smoking in Orofacial Cleft Risk.Front Cell Dev Biol. 2022 Feb 10;10:621261. doi: 10.3389/fcell.2022.621261. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35223824 Free PMC article.